US Broker Ratings

Option Care Health, Inc. (OPCH) Stock Analysis: A 31% Upside Potential Amid Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector may want to closely examine Option Care Health, Inc. (NASDAQ: OPCH), a key player in the medical care facilities industry. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 92.85% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) has recently captured investor attention with its promising position in the biotech sector, driven by innovative vaccine development and significant upside potential. With a current market..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands out as a key player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $8.05 billion, this..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 35% Upside Potential with Robust Analyst Ratings

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is making waves with its diverse portfolio of over-the-counter (OTC) health and personal care products. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a Potential 69% Upside in the Healthcare Tech Space

For investors looking at the intersection of healthcare and technology, Waystar Holding Corp. (NASDAQ: WAY) presents an intriguing opportunity. Specializing in cloud-based software solutions for healthcare payments, Waystar has carved..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 100% Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, particularly with its promising pipeline of novel cell therapies. Despite the challenges inherent in the biotech industry, Legend..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Company Poised for Nearly 90% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) stands as a compelling opportunity within the biotechnology sector, particularly for investors with an appetite for high-growth potential. With a market capitalization of $225.62 million,..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Collaborations

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, has carved a niche for itself in the healthcare industry through its innovative approach to drug development and strategic..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Stable Horizon with Strong Cash Reserves

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, commands a market capitalization of $2.76 billion. Headquartered in Redwood City, California, Soleno Therapeutics specializes in developing and..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 52.60% Revenue Growth in the Expanding Healthcare Sector

Oscar Health, Inc. (OSCR) is making waves in the healthcare sector, capturing investor attention with an impressive 52.60% revenue growth. Headquartered in New York, Oscar Health operates as a healthcare..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, with a market capitalization of $10.97 billion. Specializing in genetic medicines targeting diseases with significant..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal a Potential 30% Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing the attention of investors with its robust growth potential and favorable analyst ratings. Based in Draper,..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $7.02 billion, Avantor provides..

Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape

Tempus AI, Inc. (TEM), a healthcare technology company headquartered in Chicago, Illinois, is making waves in the health information services industry with its innovative solutions and strategic collaborations. With a..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s 80.98% ROE and Market Dynamics

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector with a focus on medical care facilities, has been a subject of keen investor interest, particularly given its impressive return..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 11.37% Potential Upside Amidst Mixed Analyst Ratings

Inspire Medical Systems, Inc. (NASDAQ: INSP) has been capturing investor attention as it operates at the cutting edge of medical technology, particularly in the treatment of obstructive sleep apnea (OSA)...

Cytokinetics, Incorporated (CYTK): Investor Outlook Reveals 28.48% Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading player in the biotechnology sector, has captured the attention of investors with its robust revenue growth and promising drug pipeline. With a current market..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 14% Potential Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a formidable entity in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $42.96 billion, BDX has..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unraveling a $38.71 Billion Biotechnology Powerhouse’s Growth Potential

Revolution Medicines, Inc. (NASDAQ: RVMD) is carving its niche in the healthcare sector, particularly in the biotechnology industry. With its focus on developing groundbreaking therapies for RAS-addicted cancers, the company..

Sarepta Therapeutics (SRPT) Stock Analysis: Unveiling a 30% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT), a leading name in the biotechnology sector, is making waves with its focus on RNA-targeted therapeutics and gene therapy for rare diseases. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds